Polish experience in Peptide receptor radionuclide therapy.


PATIENTS AND METHODS During the period from April 2004 to December 2010, 358 patients underwent peptide receptor radionuclide therapy (PRRT) ((90)Y-DOTATATE, (177)Lu-DOTATATE, and (90)Y/(177)Lu-DOTATATE) in Poland. RESULTS The majority of patients underwent (90)Y-DOTATATE therapy (n = 177) with progression-free survival (PFS)/time to progression (TTP) of… (More)
DOI: 10.1007/978-3-642-27994-2_26


Cite this paper

@article{Kunikowska2013PolishEI, title={Polish experience in Peptide receptor radionuclide therapy.}, author={Jolanta Kunikowska and Leszek Kr{\'o}licki and Anna Sowa-Staszczak and Alicja Hubalewska-Dydejczyk and Dariusz Pawlak and Renata Mikolajczak and Daria Handkiewicz-Junak and Norbert Szaluś and Grzegorz Witkor Kamiński and Jaroslaw B Cwikla and Maciej Jakuciński and Anna Lukiewicz and Aldona Kowalska and Pawel Gut}, journal={Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer}, year={2013}, volume={194}, pages={467-78} }